Literature DB >> 29950184

A predictive model for conversion to psychosis in clinical high-risk patients.

Adam J Ciarleglio1, Gary Brucato2, Michael D Masucci2, Rebecca Altschuler3, Tiziano Colibazzi2, Cheryl M Corcoran4, Francesca M Crump3, Guillermo Horga2, Eugénie Lehembre-Shiah3, Wei Leong3, Scott A Schobel5, Melanie M Wall1, Lawrence H Yang6, Jeffrey A Lieberman2, Ragy R Girgis2.   

Abstract

BACKGROUND: The authors developed a practical and clinically useful model to predict the risk of psychosis that utilizes clinical characteristics empirically demonstrated to be strong predictors of conversion to psychosis in clinical high-risk (CHR) individuals. The model is based upon the Structured Interview for Psychosis Risk Syndromes (SIPS) and accompanying clinical interview, and yields scores indicating one's risk of conversion.
METHODS: Baseline data, including demographic and clinical characteristics measured by the SIPS, were obtained on 199 CHR individuals seeking evaluation in the early detection and intervention for mental disorders program at the New York State Psychiatric Institute at Columbia University Medical Center. Each patient was followed for up to 2 years or until they developed a syndromal DSM-4 disorder. A LASSO logistic fitting procedure was used to construct a model for conversion specifically to a psychotic disorder.
RESULTS: At 2 years, 64 patients (32.2%) converted to a psychotic disorder. The top five variables with relatively large standardized effect sizes included SIPS subscales of visual perceptual abnormalities, dysphoric mood, unusual thought content, disorganized communication, and violent ideation. The concordance index (c-index) was 0.73, indicating a moderately strong ability to discriminate between converters and non-converters.
CONCLUSIONS: The prediction model performed well in classifying converters and non-converters and revealed SIPS measures that are relatively strong predictors of conversion, comparable with the risk calculator published by NAPLS (c-index = 0.71), but requiring only a structured clinical interview. Future work will seek to externally validate the model and enhance its performance with the incorporation of relevant biomarkers.

Entities:  

Keywords:  Clinical high risk; prediction model; psychosis prediction; schizophrenia

Mesh:

Year:  2018        PMID: 29950184      PMCID: PMC6374204          DOI: 10.1017/S003329171800171X

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  36 in total

1.  North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research.

Authors:  Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming Tsuang; Elaine F Walker; Scott W Woods; Robert Heinssen
Journal:  Schizophr Bull       Date:  2007-01-25       Impact factor: 9.306

2.  Distinct Relationships Between Visual and Auditory Perceptual Abnormalities and Conversion to Psychosis in a Clinical High-Risk Population.

Authors:  Eugénie Lehembre-Shiah; Wei Leong; Gary Brucato; Anissa Abi-Dargham; Jeffrey A Lieberman; Guillermo Horga; Ragy R Girgis
Journal:  JAMA Psychiatry       Date:  2017-01-01       Impact factor: 21.596

Review 3.  The psychosis high-risk state: a comprehensive state-of-the-art review.

Authors:  Paolo Fusar-Poli; Stefan Borgwardt; Andreas Bechdolf; Jean Addington; Anita Riecher-Rössler; Frauke Schultze-Lutter; Matcheri Keshavan; Stephen Wood; Stephan Ruhrmann; Larry J Seidman; Lucia Valmaggia; Tyrone Cannon; Eva Velthorst; Lieuwe De Haan; Barbara Cornblatt; Ilaria Bonoldi; Max Birchwood; Thomas McGlashan; William Carpenter; Patrick McGorry; Joachim Klosterkötter; Philip McGuire; Alison Yung
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

4.  Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?

Authors:  Alison R Yung; Hok Pan Yuen; Gregor Berger; Shona Francey; Te-Chieh Hung; Barnaby Nelson; Lisa Phillips; Patrick McGorry
Journal:  Schizophr Bull       Date:  2007-04-02       Impact factor: 9.306

5.  Impact of lifetime traumatic experiences on suicidality and likelihood of conversion in a cohort of individuals at clinical high-risk for psychosis.

Authors:  Margaux M Grivel; Wei Leong; Michael D Masucci; Rebecca A Altschuler; Leigh Y Arndt; Samantha L Redman; Lawrence H Yang; Gary Brucato; Ragy R Girgis
Journal:  Schizophr Res       Date:  2017-09-19       Impact factor: 4.939

6.  Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators.

Authors:  Robert K Nam; Michael W Kattan; Joseph L Chin; John Trachtenberg; Rajiv Singal; Ricardo Rendon; Laurence H Klotz; Linda Sugar; Christopher Sherman; Jonathan Izawa; David Bell; Aleksandra Stanimirovic; Vasundara Venkateswaran; Eleftherios P Diamandis; Changhong Yu; D Andrew Loblaw; Steven A Narod
Journal:  J Clin Oncol       Date:  2011-06-20       Impact factor: 44.544

7.  A Longitudinal Study of Violent Behavior in a Psychosis-Risk Cohort.

Authors:  Gary Brucato; Paul S Appelbaum; Jeffrey A Lieberman; Melanie M Wall; Tianshu Feng; Michael D Masucci; Rebecca Altschuler; Ragy R Girgis
Journal:  Neuropsychopharmacology       Date:  2017-07-26       Impact factor: 7.853

8.  An Individualized Risk Calculator for Research in Prodromal Psychosis.

Authors:  Tyrone D Cannon; Changhong Yu; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Robert Heinssen; Clark D Jeffries; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Michael W Kattan
Journal:  Am J Psychiatry       Date:  2016-07-01       Impact factor: 18.112

9.  The Violent Content in Attenuated Psychotic Symptoms.

Authors:  Catherine Marshall; Stephanie Deighton; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel Mathalon; Jean Addington
Journal:  Psychiatry Res       Date:  2016-05-07       Impact factor: 3.222

10.  Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia.

Authors:  Barbara A Cornblatt; Andrea M Auther; Tara Niendam; Christopher W Smith; Jamie Zinberg; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2007-04-17       Impact factor: 9.306

View more
  14 in total

Review 1.  A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk.

Authors:  Valerie J Sydnor; David R Roalf
Journal:  Schizophr Res       Date:  2020-07-25       Impact factor: 4.939

2.  Translating RDoC to Real-World Impact in Developmental Psychopathology: A Neurodevelopmental Framework for Application of Mental Health Risk Calculators.

Authors:  Leigha A MacNeill; Norrina B Allen; Roshaye B Poleon; Teresa Vargas; K Juston Osborne; Katherine S F Damme; Deanna M Barch; Sheila Krogh-Jespersen; Ashley N Nielsen; Elizabeth S Norton; Christopher D Smyser; Cynthia E Rogers; Joan L Luby; Vijay A Mittal; Lauren S Wakschlag
Journal:  Dev Psychopathol       Date:  2021-12-07

3.  The psychology of professional and student actors: Creativity, personality, and motivation.

Authors:  Denis Dumas; Michael Doherty; Peter Organisciak
Journal:  PLoS One       Date:  2020-10-22       Impact factor: 3.240

4.  An imaging-based risk calculator for prediction of conversion to psychosis in clinical high-risk individuals using glutamate 1H MRS.

Authors:  Lawrence S Kegeles; Adam Ciarleglio; Pablo León-Ortiz; Francisco Reyes-Madrigal; Jeffrey A Lieberman; Gary Brucato; Ragy R Girgis; Camilo de la Fuente-Sandoval
Journal:  Schizophr Res       Date:  2019-09-12       Impact factor: 4.939

5.  What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors.

Authors:  Dominic Oliver; Thomas J Reilly; Ottone Baccaredda Boy; Natalia Petros; Cathy Davies; Stefan Borgwardt; Philip McGuire; Paolo Fusar-Poli
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

6.  Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk.

Authors:  Diana O Perkins; Loes Olde Loohuis; Jenna Barbee; John Ford; Clark D Jeffries; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Larry J Seidman; Ming Tsuang; Elaine F Walker; Scott W Woods
Journal:  Am J Psychiatry       Date:  2019-11-12       Impact factor: 18.112

7.  Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis.

Authors:  Michelle A Worthington; Elaine F Walker; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Scott W Woods; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2020-10-09       Impact factor: 4.939

8.  Neurocognition in Kenyan youth at clinical high risk for psychosis.

Authors:  Daniel Mamah; Victoria N Mutiso; David M Ndetei
Journal:  Schizophr Res Cogn       Date:  2021-05-25

9.  Individual Differences and Psychosis-Risk Screening: Practical Suggestions to Improve the Scope and Quality of Early Identification.

Authors:  Jason Schiffman; Lauren M Ellman; Vijay A Mittal
Journal:  Front Psychiatry       Date:  2019-02-14       Impact factor: 4.157

10.  Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis.

Authors:  Gonzalo Salazar de Pablo; Filippo Besana; Vincenzo Arienti; Ana Catalan; Julio Vaquerizo-Serrano; Anna Cabras; Joana Pereira; Livia Soardo; Francesco Coronelli; Simi Kaur; Josette da Silva; Dominic Oliver; Natalia Petros; Carmen Moreno; Ana Gonzalez-Pinto; Covadonga M Díaz-Caneja; Jae Il Shin; Pierluigi Politi; Marco Solmi; Renato Borgatti; Martina Maria Mensi; Celso Arango; Christoph U Correll; Philip McGuire; Paolo Fusar-Poli
Journal:  EClinicalMedicine       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.